We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
Cap. Flow
+$417M
Cap. Flow %
8.07%
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$43.8M
2
GILD icon
Gilead Sciences
GILD
+$40.8M
3
GE icon
GE Aerospace
GE
+$37.3M
4
MSI icon
Motorola Solutions
MSI
+$24.6M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$23.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$53.2M
2
AMGN icon
Amgen
AMGN
+$30.4M
3
MJN
Mead Johnson Nutrition Company
MJN
+$21.5M
4
CNI icon
Canadian National Railway
CNI
+$20.9M
5
BDX icon
Becton Dickinson
BDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 24.05%
2 Financials 13.76%
3 Technology 12.91%
4 Communication Services 9.31%
5 Industrials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXC icon
376
Exelon
EXC
$48.6B
$2.61M 0.05%
101,724
+19,481
+24% +$496K
NSC icon
377
Norfolk Southern
NSC
$78.8B
$2.58M 0.05%
23,035
+4,521
+24% +$529K
TBPH icon
378
Theravance Biopharma
TBPH
$874M
$2.58M 0.05%
70,000
-5,000
-7% -$160K
CNC icon
379
Centene
CNC
$31.3B
$2.58M 0.05%
72,334
+11,672
+19% +$391K
HE icon
380
Hawaiian Electric Industries
HE
$2.33B
$2.57M 0.05%
77,133
-592
-0.8% -$19.6K
ENB icon
381
Enbridge
ENB
$124B
$2.56M 0.05%
61,327
+29,271
+91% +$1.24M
TRP icon
382
TC Energy
TRP
$73.5B
$2.55M 0.05%
55,488
+7,004
+14% +$327K
BAX icon
383
Baxter International
BAX
$11.6B
$2.54M 0.05%
48,963
+8,290
+20% +$408K
RVNC
384
DELISTED
Revance Therapeutics, Inc.
RVNC
$2.54M 0.05%
122,000
+55,000
+82% +$1.13M
ZTS icon
385
Zoetis
ZTS
$31.6B
$2.53M 0.05%
47,336
+9,281
+24% +$502K
WHR icon
386
Whirlpool
WHR
$2.42B
$2.48M 0.05%
14,466
-25,463
-64% -$4.52M
DELL icon
387
Dell
DELL
$283B
$2.48M 0.05%
137,741
+15,027
+12% +$262K
PCAR icon
388
PACCAR
PCAR
$69.6B
$2.45M 0.05%
54,711
+9,190
+20% +$414K
COR icon
389
Cencora
COR
$60.3B
$2.44M 0.05%
27,519
+10,933
+66% +$961K
DVA icon
390
DaVita
DVA
$15.1B
$2.43M 0.05%
35,800
+6,040
+20% +$400K
ICPT
391
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.43M 0.05%
21,500
– –
CAH icon
392
Cardinal Health
CAH
$53.4B
$2.43M 0.05%
29,748
+4,788
+19% +$377K
SQM icon
393
Sociedad Química y Minera de Chile
SQM
$19.6B
$2.41M 0.05%
+70,000
New +$2.28M
PSA icon
394
Public Storage
PSA
$60.2B
$2.4M 0.05%
10,980
+2,312
+27% +$512K
SIOX
395
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$2.39M 0.05%
20,000
+8,750
+78% +$917K
TXMD icon
396
TherapeuticsMD
TXMD
$23.8M
$2.38M 0.05%
6,600
+3,600
+120% +$1.11M
SBAC icon
397
SBA Communications
SBAC
$18.4B
$2.37M 0.05%
19,664
-12,134
-38% -$1.34M
SHW icon
398
Sherwin-Williams
SHW
$78.3B
$2.36M 0.05%
22,833
-17,208
-43% -$1.73M
CNQ icon
399
Canadian Natural Resources
CNQ
$96.9B
$2.35M 0.05%
147,126
-4,780
-3% -$72.3K
FL
400
DELISTED
Foot Locker
FL
$2.34M 0.05%
31,235
+16,000
+105% +$1.15M
14 15
16
17 18

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2017 Portfolio in Review

As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.

  • Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
  • Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
  • Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
  • Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
  • Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.